Canada markets closed

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.2150+0.0150 (+7.50%)
At close: 3:59PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 524.06M
Enterprise Value 324.15M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)10.57
Price/Book (mrq)35.83
Enterprise Value/Revenue 310.61
Enterprise Value/EBITDA 6-22.69

Trading Information

Stock Price History

Beta (5Y Monthly) 0.37
52-Week Change 379.17%
S&P500 52-Week Change 323.92%
52 Week High 30.2750
52 Week Low 30.0650
50-Day Moving Average 30.1660
200-Day Moving Average 30.1289

Share Statistics

Avg Vol (3 month) 3550.14k
Avg Vol (10 day) 3810.44k
Shares Outstanding 5111.92M
Float 99.79M
% Held by Insiders 18.60%
% Held by Institutions 16.74%
Shares Short (Feb. 11, 2021) 4337.15k
Short Ratio (Feb. 11, 2021) 40.39
Short % of Float (Feb. 11, 2021) 4N/A
Short % of Shares Outstanding (Feb. 11, 2021) 40.30%
Shares Short (prior month Jan. 14, 2021) 499.96k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin -84.21%
Operating Margin (ttm)-51.53%

Management Effectiveness

Return on Assets (ttm)-23.19%
Return on Equity (ttm)-468.76%

Income Statement

Revenue (ttm)2.28M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)66.90%
Gross Profit (ttm)1.63M
EBITDA -1.06M
Net Income Avi to Common (ttm)-1.92M
Diluted EPS (ttm)-0.0220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.34M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)2.43M
Total Debt/Equity (mrq)383.77
Current Ratio (mrq)4.19
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-532.81k
Levered Free Cash Flow (ttm)-712.64k